Safety and Feasibility of Metformin for Sepsis Induced AKI

Clinical trial NCT05900284 · COMPLETED

Trial details

NCT number: NCT05900284
Sponsor: Hernando Gomez
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis Septic Shock Acute Kidney Injury Metformin

Start date: 2023-11-08
Primary completion: 2026-05-18
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.